Central Trust Company’s Savara SVRA Stock Holding History

Central Trust Company’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-42	Closed	–	–	1214
2019 Q3	$0	Buy	+42	New	+$105	﹤0.01%	1193

Other funds holding SVRA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Central Trust Company's SVRA Position: Q4 2019 in Review

Central Trust Company sold out of Savara (SVRA) in Q4 2019, closing a stake of 42 shares.

Central Trust Company first reported a position in SVRA in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 78 funds tracked by Wall St. Rank hold SVRA as of Q4 2019.

Central Trust Company reported no remaining Savara position as of Q4 2019 after selling out during the quarter.
Central Trust Company sold 42 Savara shares in Q4 2019.
Central Trust Company first reported a position in Savara in Q3 2019 and held it in 1 quarter.
Central Trust Company's Savara position peaked at $0 in Q3 2019.
78 funds tracked by Wall St. Rank held Savara as of Q4 2019.

Based on Central Trust Company's 13F filing for Q4 2019, filed 21 Jan 2020.